Metlife stock kpis
Want to see MET full AI Analyst Report?
Net Premiums Earned by Segment
Metlife reported net premiums earned by segment of $11.44B in Q2 2026, down 5.7% from Q1 2026 and up 5.8% year over year. The highest value was $17.55B in Q3 2022.
Shows the premiums recognized as revenue after accounting for unearned portions, broken down by business line. Tracks where sales and renewal momentum are coming from and highlights exposure to shifts in market demand, pricing, or changes in product mix across MetLife’s segments.
Since 2023 the premium mix has shifted materially: US premiums largely disappear while Group Benefits has become a steady, predictable revenue base and RIS shows pronounced, lumpy volatility driven by large institutional transactions. Asia, LATAM and EMEA exhibit steady expansion—matching management’s call-outs of regional outperformance—while Corporate & Other posts episodic swings that align with capital actions and reclassifications discussed on the call. Investment/VII performance and the timing of RIS transactions will therefore be the primary drivers of near‑term earnings volatility despite healthier underlying sales.
MET Net Premiums Earned by Segment
| Period | US | Group Benefits | Retirement & Income Solutions | Asia | LATAM | EMEA | Metlife Holdings | Corporate & Other | mim | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026Jun 30, 2026 | $0.00 | $5.82B | $1.59B | $1.24B | $1.50B | $698.00M | $0.00 | $596.00M | $0.00 | $11.44B |
| Q1 2026Mar 31, 2026 | $0.00 | $5.85B | $2.21B | $1.29B | $1.49B | $689.00M | $0.00 | $592.00M | $0.00 | $12.12B |
| Q4 2025Dec 31, 2025 | $0.00 | $5.63B | $7.03B | $1.22B | $1.44B | $679.00M | $0.00 | $684.00M | $0.00 | $16.69B |
| Q3 2025Sep 30, 2025 | $0.00 | $5.66B | $1.04B | $1.29B | $1.29B | $638.00M | $0.00 | $632.00M | $0.00 | $10.55B |
| Q2 2025Jun 30, 2025 | $0.00 | $5.80B | $1.21B | $1.28B | $1.26B | $626.00M | $0.00 | $632.00M | $0.00 | $10.81B |
| Q1 2025Mar 31, 2025 | $0.00 | $5.76B | $2.28B | $1.26B | $1.16B | $582.00M | $0.00 | $666.00M | $0.00 | $11.72B |
| Q4 2024Dec 31, 2024 | $0.00 | $5.58B | $3.46B | $1.21B | $1.10B | $568.00M | $702.00M | -$11.00M | $0.00 | $12.60B |
| Q3 2024Sep 30, 2024 | $0.00 | $5.54B | $1.45B | $1.27B | $1.14B | $562.00M | $673.00M | -$6.00M | $0.00 | $10.63B |
| Q2 2024Jun 30, 2024 | $0.00 | $5.60B | $2.45B | $1.22B | $1.12B | $536.00M | $692.00M | $15.00M | $0.00 | $11.63B |
| Q1 2024Mar 31, 2024 | $0.00 | $5.71B | $675.00M | $1.30B | $1.11B | $536.00M | $713.00M | $6.00M | $0.00 | $10.05B |
| Q4 2023Dec 31, 2023 | $0.00 | $5.40B | $2.74B | $1.25B | $1.12B | $519.00M | $754.00M | -$2.00M | $0.00 | $11.79B |
| Q3 2023Sep 30, 2023 | $0.00 | $5.28B | $2.33B | $1.31B | $1.12B | $502.00M | $685.00M | $9.00M | $0.00 | $11.23B |
| Q2 2023Jun 30, 2023 | $0.00 | $5.43B | $2.68B | $1.31B | $1.02B | $499.00M | $719.00M | $19.00M | $0.00 | $11.68B |
| Q1 2023Mar 31, 2023 | $0.00 | $5.45B | $501.00M | $1.38B | $1.02B | $496.00M | $723.00M | $16.00M | $0.00 | $9.59B |
| Q4 2022Dec 31, 2022 | $5.97B | $0.00 | $0.00 | $1.27B | $845.00M | $488.00M | $785.00M | $1.00M | $0.00 | $9.36B |
| Q3 2022Sep 30, 2022 | $14.16B | $0.00 | $0.00 | $1.35B | $823.00M | $475.00M | $745.00M | -$7.00M | $0.00 | $17.55B |
| Q2 2022Jun 30, 2022 | $8.25B | $0.00 | $0.00 | $1.40B | $826.00M | $492.00M | $760.00M | -$6.00M | $0.00 | $11.72B |
| Q1 2022Mar 31, 2022 | $7.16B | $0.00 | $0.00 | $1.55B | $732.00M | $509.00M | $776.00M | -$4.00M | $0.00 | $10.73B |
| Q4 2021Dec 31, 2021 | $4.16B | $0.00 | $0.00 | $1.56B | $673.00M | $520.00M | $862.00M | -$19.00M | $0.00 | $7.76B |
| Q3 2021Sep 30, 2021 | $740.00M | $0.00 | $0.00 | $1.59B | $705.00M | $532.00M | $805.00M | $16.00M | $0.00 | $4.39B |
| Q2 2021Jun 30, 2021 | $389.00M | $0.00 | $0.00 | $1.58B | $636.00M | $621.00M | $839.00M | -$20.00M | $0.00 | $4.05B |
| Q1 2021Mar 31, 2021 | $593.00M | $0.00 | $0.00 | $1.69B | $595.00M | $598.00M | $827.00M | $58.00M | $0.00 | $4.36B |

